Prof. John Charles Chaput 

Abstract: The birth of biotechnology marked a defining moment in American science that launched a multi-billion-dollar industry built on the concept that enzymes found in nature could be used to improve human health. This relatively simple idea revolutionized medicine by providing the tools need to synthesize, sequence, and manipulate DNA with exquisite precision. The panoply …

Prof. John Charles Chaput  Read More »

Prof. John Charles Chaput

Abstract: The birth of biotechnology marked a defining moment in American science that launched a multi-billion-dollar industry built on the concept that enzymes found in nature could be used to improve human health. This relatively simple idea revolutionized medicine by providing the tools need to synthesize, sequence, and manipulate DNA with exquisite precision. The panoply …

Prof. John Charles Chaput Read More »

Prof. Yulia Gerasimova

Abstract: Nucleic acid interrogation with colorimetric and fluorescent DNA probes: Nucleic acid analysis has benefited from the development of hybridization probes that interrogate nucleic acids in a sequence-specific manner. We have efficiently utilized a split approach for the design of hybridization probes based on deoxyribozymes and aptamers as scaffolds. In split probes, analyte-recognizing fragment of …

Prof. Yulia Gerasimova Read More »

Dr. Igor Jurisica

AI is Not Enough: Explainable Biology for Improved Therapies: Integrative computational biology and AI help improving treatment of complex diseases by building explainable models. From systematic data analysis to improved biomarkers, drug mechanism of action, and patient selection, such analyses influence multiple steps of drug discovery pipeline. Data mining, machine learning, graph theory and advanced …

Dr. Igor Jurisica Read More »

Dr. Frank Delaglio

Abstract Protein therapeutics are a highly successful class of drugs that are used to treat a number of serious and life-threatening conditions such as cancer, autoimmune disorders, and infectious diseases including COVID-19.  These therapeutics have numerous critical quality attributes (CQA) that must be evaluated to ensure safety and efficacy, including that they must adopt and …

Dr. Frank Delaglio Read More »